Diane Renee Abraczinskas, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Sarcoma, Myeloid | 1 | 2020 | 52 | 0.690 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2020 | 957 | 0.410 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2020 | 3626 | 0.230 |
Why?
|
| Esophageal and Gastric Varices | 2 | 2001 | 215 | 0.200 |
Why?
|
| Hyperbilirubinemia | 1 | 2000 | 74 | 0.180 |
Why?
|
| Propranolol | 1 | 2001 | 493 | 0.170 |
Why?
|
| Endoscopy, Digestive System | 1 | 2020 | 358 | 0.150 |
Why?
|
| Duodenum | 1 | 2020 | 495 | 0.140 |
Why?
|
| Intestinal Diseases | 1 | 2021 | 505 | 0.140 |
Why?
|
| Interferon-alpha | 3 | 2009 | 909 | 0.130 |
Why?
|
| Stomach | 1 | 2020 | 701 | 0.130 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2001 | 1243 | 0.130 |
Why?
|
| Gastrins | 1 | 1995 | 75 | 0.120 |
Why?
|
| Sp1 Transcription Factor | 1 | 1995 | 143 | 0.120 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2001 | 1126 | 0.110 |
Why?
|
| Ischemia | 1 | 2021 | 1905 | 0.100 |
Why?
|
| Hepatitis C, Chronic | 1 | 2000 | 1032 | 0.100 |
Why?
|
| Liver Transplantation | 2 | 2003 | 2416 | 0.100 |
Why?
|
| Epidermal Growth Factor | 1 | 1995 | 697 | 0.100 |
Why?
|
| Hepatitis C | 3 | 2009 | 1594 | 0.090 |
Why?
|
| Adenoma | 1 | 2021 | 2155 | 0.090 |
Why?
|
| Post-Exposure Prophylaxis | 1 | 2009 | 113 | 0.080 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2009 | 249 | 0.070 |
Why?
|
| Antiviral Agents | 2 | 2009 | 3070 | 0.060 |
Why?
|
| Polyethylene Glycols | 1 | 2009 | 1188 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 1995 | 5796 | 0.050 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5716 | 0.050 |
Why?
|
| Cholestasis, Intrahepatic | 1 | 2002 | 75 | 0.050 |
Why?
|
| Ribavirin | 1 | 2003 | 395 | 0.050 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 6966 | 0.050 |
Why?
|
| DNA | 1 | 1995 | 7210 | 0.050 |
Why?
|
| Laparotomy | 1 | 2021 | 459 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2000 | 526 | 0.040 |
Why?
|
| Hepacivirus | 2 | 2009 | 1342 | 0.040 |
Why?
|
| Virus Activation | 1 | 2000 | 322 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15824 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2000 | 631 | 0.040 |
Why?
|
| Galanin | 1 | 1997 | 42 | 0.040 |
Why?
|
| Pituitary Gland, Anterior | 1 | 1997 | 142 | 0.040 |
Why?
|
| Triiodothyronine | 1 | 1997 | 493 | 0.030 |
Why?
|
| Health Personnel | 1 | 2009 | 3387 | 0.030 |
Why?
|
| Middle Aged | 6 | 2021 | 223233 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1995 | 848 | 0.030 |
Why?
|
| Thyroxine | 1 | 1997 | 666 | 0.030 |
Why?
|
| Male | 8 | 2021 | 364203 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2001 | 4855 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2021 | 1409 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1995 | 1729 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 1997 | 667 | 0.030 |
Why?
|
| Mutagenesis, Insertional | 1 | 1995 | 661 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2000 | 4838 | 0.020 |
Why?
|
| Recurrence | 2 | 2003 | 8504 | 0.020 |
Why?
|
| Liver Cirrhosis | 1 | 2002 | 1959 | 0.020 |
Why?
|
| Transfection | 2 | 1997 | 5753 | 0.020 |
Why?
|
| Estradiol | 1 | 1997 | 1951 | 0.020 |
Why?
|
| Graft Rejection | 1 | 2003 | 4498 | 0.020 |
Why?
|
| Blood-Borne Pathogens | 1 | 2009 | 52 | 0.020 |
Why?
|
| Needlestick Injuries | 1 | 2009 | 71 | 0.020 |
Why?
|
| Humans | 9 | 2021 | 767040 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2001 | 10092 | 0.020 |
Why?
|
| Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
| Base Sequence | 2 | 1997 | 12414 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2001 | 12451 | 0.020 |
Why?
|
| Sex Factors | 1 | 2021 | 10622 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 6507 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2021 | 3236 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 17608 | 0.020 |
Why?
|
| Cell Line | 2 | 1997 | 15567 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 1997 | 7611 | 0.010 |
Why?
|
| Prednisolone | 1 | 2003 | 326 | 0.010 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 415 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2009 | 2867 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 5794 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1997 | 11923 | 0.010 |
Why?
|
| Female | 4 | 2021 | 396660 | 0.010 |
Why?
|
| Occupational Exposure | 1 | 2009 | 1807 | 0.010 |
Why?
|
| Propylthiouracil | 1 | 1997 | 68 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2002 | 1836 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 54886 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2002 | 1615 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2009 | 8732 | 0.010 |
Why?
|
| Transcription Factors | 1 | 1995 | 12158 | 0.010 |
Why?
|
| HIV Infections | 1 | 2002 | 17542 | 0.010 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1997 | 792 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2003 | 2163 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1997 | 1526 | 0.010 |
Why?
|
| Acute Disease | 1 | 2003 | 7236 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2003 | 4210 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1997 | 3738 | 0.000 |
Why?
|
| Animals | 2 | 1997 | 168965 | 0.000 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1997 | 8108 | 0.000 |
Why?
|
| Disease Progression | 1 | 2002 | 13646 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 15925 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2009 | 65295 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1997 | 12793 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1997 | 18989 | 0.000 |
Why?
|
| Rats | 1 | 1997 | 23713 | 0.000 |
Why?
|
| Adult | 2 | 2003 | 223317 | 0.000 |
Why?
|
| Aged | 1 | 2003 | 171319 | 0.000 |
Why?
|